Mead Johnson Nutrition CO (MJN) : Holowesko Partners Ltd. scooped up 66,000 additional shares in Mead Johnson Nutrition CO during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 10, 2016. The investment management firm now holds a total of 1,351,743 shares of Mead Johnson Nutrition CO which is valued at $113,154,407.Mead Johnson Nutrition CO makes up approximately 8.84% of Holowesko Partners Ltd.’s portfolio.
Other Hedge Funds, Including , Blackrock Fund Advisors reduced its stake in MJN by selling 225,568 shares or 6.99% in the most recent quarter. The Hedge Fund company now holds 3,003,207 shares of MJN which is valued at $251,398,458. Mead Johnson Nutrition CO makes up approx 0.06% of Blackrock Fund Advisors’s portfolio.Cibc Asset Management Inc boosted its stake in MJN in the latest quarter, The investment management firm added 152 additional shares and now holds a total of 22,185 shares of Mead Johnson Nutrition CO which is valued at $1,857,106. Mead Johnson Nutrition CO makes up approx 0.01% of Cibc Asset Management Inc’s portfolio.Schwab Charles Investment Management Inc reduced its stake in MJN by selling 10,407 shares or 2.01% in the most recent quarter. The Hedge Fund company now holds 507,600 shares of MJN which is valued at $43,171,380. Mead Johnson Nutrition CO makes up approx 0.06% of Schwab Charles Investment Management Inc’s portfolio.Gabelli Funds boosted its stake in MJN in the latest quarter, The investment management firm added 8,800 additional shares and now holds a total of 150,300 shares of Mead Johnson Nutrition CO which is valued at $12,783,015. Mead Johnson Nutrition CO makes up approx 0.08% of Gabelli Funds’s portfolio.Texas Permanent School Fund reduced its stake in MJN by selling 5,806 shares or 8.28% in the most recent quarter. The Hedge Fund company now holds 64,303 shares of MJN which is valued at $5,604,006. Mead Johnson Nutrition CO makes up approx 0.07% of Texas Permanent School Fund’s portfolio.
Mead Johnson Nutrition CO opened for trading at $83.68 and hit $85.08 on the upside on Monday, eventually ending the session at $84.85, with a gain of 1.36% or 1.14 points. The heightened volatility saw the trading volume jump to 8,34,964 shares. Company has a market cap of $15,838 M.
On the company’s financial health, Mead Johnson Nutrition CO reported $0.87 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.84. The company had revenue of $962.10 million for the quarter, compared to analysts expectations of $954.99 million. The company’s revenue was down -12.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.09 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. Mead Johnson Nutrition CO was Upgraded by Credit Suisse to ” Outperform” on Mar 16, 2016.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.